Rocket Pharmaceuticals Stock Forecast, Price & News

Rocket Pharmaceuticals (NASDAQ:RCKT) Frequently Asked Questions

Is Rocket Pharmaceuticals a buy right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Rocket Pharmaceuticals in the last year. There are currently 1 hold rating and 9 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Rocket Pharmaceuticals stock.
View analyst ratings for Rocket Pharmaceuticals or view top-rated stocks.

How has Rocket Pharmaceuticals' stock price been impacted by Coronavirus?

Rocket Pharmaceuticals' stock was trading at $15.99 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, RCKT shares have increased by 48.0% and is now trading at $23.67.
View which stocks have been most impacted by COVID-19.

When is Rocket Pharmaceuticals' next earnings date?

Rocket Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for Rocket Pharmaceuticals.

How were Rocket Pharmaceuticals' earnings last quarter?

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) issued its earnings results on Wednesday, November, 3rd. The biotechnology company reported ($0.79) EPS for the quarter, missing analysts' consensus estimates of ($0.60) by $0.19. During the same quarter in the previous year, the business earned ($0.53) earnings per share.
View Rocket Pharmaceuticals' earnings history.

What price target have analysts set for RCKT?

10 Wall Street analysts have issued 1 year target prices for Rocket Pharmaceuticals' shares. Their forecasts range from $56.00 to $100.00. On average, they anticipate Rocket Pharmaceuticals' share price to reach $73.14 in the next year. This suggests a possible upside of 209.0% from the stock's current price.
View analysts' price targets for Rocket Pharmaceuticals or view top-rated stocks among Wall Street analysts.

Who are Rocket Pharmaceuticals' key executives?

Rocket Pharmaceuticals' management team includes the following people:

• Gaurav Shah, President, Chief Executive Officer & Director
• Kinnari Patel, Chief Operating Officer & EVP-Development
• Carlos Garcia-Parada, Chief Financial Officer
• Jonathan David Schwartz, Chief Medical Officer & SVP-Clinical Development
• Isabel Carmona, Chief Human Resources Officer & Senior VP

Who are some of Rocket Pharmaceuticals' key competitors?

Some companies that are related to Rocket Pharmaceuticals include HUTCHMED (HCM), Blueprint Medicines (BPMC), BridgeBio Pharma (BBIO), Mawson Infrastructure Group (WIZP), Ultragenyx Pharmaceutical (RARE), Perrigo (PRGO), I-Mab (IMAB), Cerevel Therapeutics (CERE), Allakos (ALLK), Arvinas (ARVN), Ionis Pharmaceuticals (IONS), Karuna Therapeutics (KRTX), Apellis Pharmaceuticals (APLS), 23andMe (ME) and Alkermes (ALKS).
View all of RCKT's competitors.

What other stocks do shareholders of Rocket Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rocket Pharmaceuticals investors own include Nymox Pharmaceutical (NYMX), Pfizer (PFE), SCYNEXIS (SCYX), Sorrento Therapeutics (SRNE), Amarin (AMRN), Energy Transfer (ET), Micron Technology (MU), VBI Vaccines (VBIV), Vaxart (VXRT) and Alibaba Group (BABA).

What is Rocket Pharmaceuticals' stock symbol?

Rocket Pharmaceuticals trades on the NASDAQ under the ticker symbol "RCKT."

Who are Rocket Pharmaceuticals' major shareholders?

Rocket Pharmaceuticals' stock is owned by many different retail and institutional investors. Top institutional investors include RTW Investments LP (24.52%), Wellington Management Group LLP (5.19%), BlackRock Inc. (5.00%), Maverick Capital Ltd. (2.58%), Franklin Resources Inc. (2.09%) and Janus Henderson Group PLC (1.91%). Company insiders that own Rocket Pharmaceuticals stock include Gotham Makker, Kinnari Patel and Rtw Investments, Lp.
View institutional ownership trends for Rocket Pharmaceuticals.

Which institutional investors are selling Rocket Pharmaceuticals stock?

RCKT stock was sold by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Lord Abbett & CO. LLC, Invesco Ltd., Dimensional Fund Advisors LP, BNP Paribas Arbitrage SA, Franklin Resources Inc., Great Point Partners LLC, and Affinity Asset Advisors LLC. Company insiders that have sold Rocket Pharmaceuticals company stock in the last year include Gotham Makker, Kinnari Patel, and Rtw Investments, Lp.
View insider buying and selling activity for Rocket Pharmaceuticals or view top insider-selling stocks.

Which institutional investors are buying Rocket Pharmaceuticals stock?

RCKT stock was bought by a variety of institutional investors in the last quarter, including Maverick Capital Ltd., RTW Investments LP, Nordea Investment Management AB, Goldman Sachs Group Inc., Barclays PLC, Renaissance Technologies LLC, Alliancebernstein L.P., and UBS Group AG. Company insiders that have bought Rocket Pharmaceuticals stock in the last two years include Kinnari Patel, and Rtw Investments, Lp.
View insider buying and selling activity for Rocket Pharmaceuticals or or view top insider-buying stocks.

How do I buy shares of Rocket Pharmaceuticals?

Shares of RCKT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Rocket Pharmaceuticals' stock price today?

One share of RCKT stock can currently be purchased for approximately $23.67.

How much money does Rocket Pharmaceuticals make?

Rocket Pharmaceuticals has a market capitalization of $1.53 billion. The biotechnology company earns $-139.70 million in net income (profit) each year or ($3.07) on an earnings per share basis.

How many employees does Rocket Pharmaceuticals have?

Rocket Pharmaceuticals employs 101 workers across the globe.

What is Rocket Pharmaceuticals' official website?

The official website for Rocket Pharmaceuticals is www.rocketpharma.com.

Where are Rocket Pharmaceuticals' headquarters?

Rocket Pharmaceuticals is headquartered at 350 FIFTH AVENUE SUITE 7530, NEW YORK NY, 10118.

How can I contact Rocket Pharmaceuticals?

Rocket Pharmaceuticals' mailing address is 350 FIFTH AVENUE SUITE 7530, NEW YORK NY, 10118. The biotechnology company can be reached via phone at (646) 440-9100, via email at [email protected], or via fax at 646-224-9585.